Save your place

Sign in to WhoBought

Please try again later.

Verve Therapeutics, Inc. (VERV) institutional ownership

Market cap$994M SectorHealthcare
Funds holding · Q1 2026
1
reported VERV position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
0 buyers · 1 sellers

Verve Therapeutics, Inc. (VERV) price and institutional activity

Dates

Q1 2026

$0 bought by 0 investors
$0 sold by 1 investors
DekaBank Deutsche Girozentrale
Bought Sold Totals per quarter; hover a bar for the names.

Verve Therapeutics, Inc. (VERV) institutional activity · 1

Investor Type Est. change Change Δ Own Date
DekaBank Deutsche Girozentrale · Exited
Change −24K Δ Own −100.0% Date Q1 2026
DekaBank Deutsche Girozentrale Exited· Q1 2026 −24K −100.0% Q1 2026
Data through Q1 2026 · filed Q1 2026
1 of 1

Famous investor activity in Verve Therapeutics, Inc. (VERV)

Verve Therapeutics, Inc. (VERV) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Gv 2017 Gp, L.L.C. · 10% Owner 3 operations -12.2M
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Gv 2017 Gp, L.L.C. 10% Owner 3 operations -12.2M 0 Jul 25, 2025 Jul 28, 2025
Lister Troy · Officer Other Form 4 events -7K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Lister Troy Officer Other Form 4 events -7K 0 Jul 25, 2025 Jul 28, 2025
Lister Troy · Officer 6 operations -385K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Lister Troy Officer 6 operations -385K 0 Jul 25, 2025 Jul 28, 2025
Maclean Michael F. · Director 2 operations -178K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Maclean Michael F. Director 2 operations -178K 0 Jul 25, 2025 Jul 28, 2025
Yeshwant Krishna · Director, 10% Owner 3 operations -12.2M
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Yeshwant Krishna Director, 10% Owner 3 operations -12.2M 0 Jul 25, 2025 Jul 28, 2025
Yeshwant Krishna · Director, 10% Owner 2 operations -178K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Yeshwant Krishna Director, 10% Owner 2 operations -178K 0 Jul 25, 2025 Jul 28, 2025
Dorval Allison · Officer Other Form 4 events -13K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Dorval Allison Officer Other Form 4 events -13K 0 Jul 25, 2025 Jul 28, 2025
Dorval Allison · Officer 6 operations -594K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Dorval Allison Officer 6 operations -594K 0 Jul 25, 2025 Jul 28, 2025
Nickerson Joan · Officer Other Form 4 events -17K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Nickerson Joan Officer Other Form 4 events -17K 0 Jul 25, 2025 Jul 28, 2025
Nickerson Joan · Officer 6 operations -517K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Nickerson Joan Officer 6 operations -517K 0 Jul 25, 2025 Jul 28, 2025
Kathiresan Sekar · Director, Officer 3 operations -700K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Kathiresan Sekar Director, Officer 3 operations -700K 0 Jul 25, 2025 Jul 28, 2025
Kathiresan Sekar · Director, Officer 10 operations -2.7M
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Kathiresan Sekar Director, Officer 10 operations -2.7M 0 Jul 25, 2025 Jul 28, 2025
Adelman Burt A. · Director Other Form 4 events -428K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Adelman Burt A. Director Other Form 4 events -428K 0 Jul 25, 2025 Jul 28, 2025
Adelman Burt A. · Director 3 operations -222K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Adelman Burt A. Director 3 operations -222K 0 Jul 25, 2025 Jul 28, 2025
Coats Lonnel · Director 2 operations -178K
Owned 0 Trade date Jul 25, 2025 Filed date Jul 28, 2025
Coats Lonnel Director 2 operations -178K 0 Jul 25, 2025 Jul 28, 2025
15 of 23
15 of 23 Sign in to continue to older insider transactions.

Verve Therapeutics, Inc. (VERV) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ark Investment Management LLC 7.0M
% of shares outstanding 8.7% Filing date Jan 29, 2024
Ark Investment Management LLC 7.0M 8.7% Jan 29, 2024
Blackrock, Inc. 7.3M
% of shares outstanding 8.6% Filing date Nov 8, 2024
Blackrock, Inc. 7.3M 8.6% Nov 8, 2024
Singer James R 5.0M
% of shares outstanding 8.1% Filing date Feb 14, 2023
Singer James R 5.0M 8.1% Feb 14, 2023
Pentwater Capital Management LP 6.7M
% of shares outstanding 7.5% Filing date Aug 14, 2025
Pentwater Capital Management LP 6.7M 7.5% Aug 14, 2025
BlackRock Inc. 4.4M
% of shares outstanding 5.6% Filing date Jan 29, 2024
BlackRock Inc. 4.4M 5.6% Jan 29, 2024
Millennium Management LLC 4.6M
% of shares outstanding 5.4% Filing date Sep 9, 2024
Millennium Management LLC 4.6M 5.4% Sep 9, 2024
Arch Venture Fund X, L.P. 2.5M
% of shares outstanding 5.2% Filing date Feb 9, 2022
Arch Venture Fund X, L.P. 2.5M 5.2% Feb 9, 2022
State Street Corp 4.3M
% of shares outstanding 5.0% Filing date Oct 16, 2024
State Street Corp 4.3M 5.0% Oct 16, 2024
8 of 15

Verve Therapeutics, Inc. (VERV) ownership FAQ

Who owns VERV?

1 reporting institutions disclosed VERV position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.